Comparison of 3 methods to induce acute pulmonary hypertension in pigs

Comparative Medicine

Volumn 59, Issue 3, 2009, Pages 280-286

  Roehl, Anna B ^a   Steendijk, Paul ^b   Baumert, Jan H ^a   Schnoor, Joerg ^a   Rossaint, Rolf ^a   Hein, Marc ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; POLYSTYRENE; VASOCONSTRICTOR AGENT;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD PRESSURE; CARDIOVASCULAR AUTOREGULATION; CONTINUOUS INFUSION; HEART AFTERLOAD; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; IMPEDANCE; INTERMETHOD COMPARISON; LUNG CIRCULATION; LUNG GAS EXCHANGE; LUNG RESISTANCE; NONHUMAN; PULMONARY HYPERTENSION; SHOCK; SWINE; SYSTEMIC CIRCULATION; ANIMAL; BALLOON OCCLUSION; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FORWARD HEART FAILURE; LUNG EMBOLISM; METHODOLOGY; PATHOPHYSIOLOGY; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACUTE DISEASE; ANIMALS; BALLOON OCCLUSION; CARDIAC OUTPUT, LOW; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; PULMONARY EMBOLISM; SWINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 68349100122     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aalkjaer C, Poston L. 1996. Effects of pH on vascular tension: which are the important mechanisms? J Vasc Res 33:347-359.
2. Baan J, van der Velde ET, de Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B. 1984. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70:812-823.
3. Bauer EP, Kuki S, Zimmermann R, Schaper W. 1998. Upregulated and downregulated transcription of myocardial genes after pulmonary artery banding in pigs. Ann Thorac Surg 66:527-531.
4. Brimioulle S, Maggiorini M, Stephanazzi J, Vermeulen F, Lejeune P, Naeije R. 1999. Effects of low flow on pulmonary vascular flow - pressure curves and pulmonary vascular impedance. Cardiovasc Res 42:183-192.
5. Campian ME, Hardziyenka M, Michel MC, Tan HL. 2006. How valid are animal models to evaluate treatments for pulmonary hypertension? Naunyn Schmiedebergs Arch Pharmacol 373:391-400.
6. Chen EP, Bittner HB, Davis RD, Van Trigt P. 1997. Pulmonary vascular impedance and recipient chronic pulmonary hypertension following cardiac transplantation. Chest 112:1622-1629.
7. Farber HW, Loscalzo J. 2004. Pulmonary arterial hypertension. N Engl J Med 351:1655-1665.
8. Guth BD, Schulz R, Heusch G. 1991. Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine. Pflugers Arch 419:622-628.
9. Hedenstierna G, Hammond M, Mathieu-Costello O, Wagner PD. 2000. Functional lung unit in the pig. Respir Physiol 120:139-149.
10. Hein M, Roehl AB, Baumert JH, Bantes B, Bleilevens C, Bernstein N, Steendijk P, Rossaint R. 2008. Establishment of a porcine right ventricular infarction model for cardioprotective actions of xenon and isoflurane. Acta Anaesthesiol Scand 52:1194-1203.
11. Holzgrefe HH, Buchanan LV, Bunting S. 1987. In vivo characterization of synthetic thromboxane A2 in canine myocardium. Circ Res 60:290-296.
12. Hon JK, Steendijk P, Khan H, Wong K, Yacoub M. 2001. Acute effects of pulmonary artery banding in sheep on right ventricle pressure-volume relations: relevance to the arterial switch operation. Acta Physiol Scand 172:97-106.
13. Institute of Laboratory Animal Resources. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press.
14. Kealey GP, Brody MJ. 1977. Studies on the mechanism of pulmonary vascular responses to miliary pulmonary embolism. Circ Res 41:807-814.
15. Kuehne T, Yilmaz S, Steendijk P, Moore P, Groenink M, Saaed M, Weber O, Higgins CB, Ewert P, Fleck E, Nagel E, Schulze-Neick I, Lange P. 2004. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 110:2010-2016.
16. Kuriyama T, Wagner WWJ. 1981. Collateral ventilation may protect against high-altitude pulmonary hypertension. J Appl Physiol 51:1251-1256.
17. Maggiorini M, Brimioulle S, De Canniere D, Delcroix M, Naeije R. 1998. Effects of pulmonary embolism on pulmonary vascular impedance in dogs and minipigs. J Appl Physiol 84:815-821.
18. Martinez RR, Setty S, Zong P, Tune JD, Downey HF. 2005. Nitric oxide contributes to right coronary vasodilation during systemic hypoxia. Am J Physiol Heart Circ Physiol 288:H1139-H1146.
19. Smulders YM. 2000. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 48:23-33.
20. Steendijk P, Staal E, Jukema JW, Baan J. 2001. Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281:H755-H763.
21. Tucker A, Rhodes J. 2001. Role of vascular smooth muscle in the development of high altitude pulmonary hypertension: an interspecies evaluation. High Alt Med Biol 2:173-189.
22. Wauthy P, Abdel Kafi S, Mooi WJ, Naeije R, Brimioulle S. 2003. Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg 126:1434-1441.
23. Young I, Mazzone RW, Wagner PD. 1980. Identification of functional lung unit in the dog by graded vascular embolization. J Appl Physiol 49:132-141.